141 related articles for article (PubMed ID: 3315317)
41. Diagnostic value of immunological leukemia phenotyping.
Drexler HG; Menon M; Gignac SM; Misra B; Minowada J
Acta Haematol; 1986; 76(1):1-8. PubMed ID: 3098021
[TBL] [Abstract][Full Text] [Related]
42. Neurological complications of leukemia and lymphoma.
Haaxma-Reiche H
Handb Clin Neurol; 2012; 105():711-29. PubMed ID: 22230529
[No Abstract] [Full Text] [Related]
43. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
Lynch RC; Gratzinger D; Advani RH
Curr Treat Options Oncol; 2017 Jul; 18(7):45. PubMed ID: 28670664
[TBL] [Abstract][Full Text] [Related]
44. Cytologic diagnosis of leukemia and lymphoma. Values and limitations.
Katz RL
Clin Lab Med; 1991 Jun; 11(2):469-99. PubMed ID: 1873967
[TBL] [Abstract][Full Text] [Related]
45. [The principles of the differential diagnosis of mature-cell lymphatic tumors].
Vorob'ev AI; Iakhnina EI; Samoĭlov RS
Ter Arkh; 1995; 67(7):3-7. PubMed ID: 7482300
[No Abstract] [Full Text] [Related]
46. [Malignant lymphoma and leukemia concepts in new WHO classification].
Kikuchi M
Rinsho Byori; 2003 Aug; 51(8):820-4. PubMed ID: 13677944
[TBL] [Abstract][Full Text] [Related]
47. [Use of monoclonal antibodies. A new era in hematology].
Obłakowski P
Acta Haematol Pol; 1983; 14(3-4):219-27. PubMed ID: 6380186
[No Abstract] [Full Text] [Related]
48. [Monoclonal antibodies against hematopoietic stem cells].
Robak T
Postepy Hig Med Dosw; 1986; 40(2):113-58. PubMed ID: 3532073
[No Abstract] [Full Text] [Related]
49. Lymphoma studies by the Australasian Leukaemia and Lymphoma Group.
Lowenthal RM; Stone JM
Transfus Apher Sci; 2013 Oct; 49(2):110-2. PubMed ID: 23962397
[TBL] [Abstract][Full Text] [Related]
50. Childhood cancer: common cancers.
Campbell R
Nurs Mirror; 1980 Aug; 151(9):viii-xii. PubMed ID: 6902351
[No Abstract] [Full Text] [Related]
51. Computerised algorithm of tumour-associated markers to monitor haematopoietic malignancy.
Venkatanarayanan S; Nagarajan B
Comput Methods Programs Biomed; 1990 Jan; 31(1):63-70. PubMed ID: 2311370
[TBL] [Abstract][Full Text] [Related]
52. Manual for coding and reporting haematological malignancies.
HAEMACARE Working Group
Tumori; 2010; 96(4):i-A32. PubMed ID: 20968151
[No Abstract] [Full Text] [Related]
53. [Leukemias and malignant lymphomas in children].
Schmiegelow K
Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
[No Abstract] [Full Text] [Related]
54. Lymphosarcoma cell leukemia and other non-Hodgkin's lymphomas in leukemic phase.
Mintzer DM; Hauptman SP
Am J Med; 1983 Jul; 75(1):110-20. PubMed ID: 6344632
[TBL] [Abstract][Full Text] [Related]
55. Biochemical monitoring of cancer. A review.
Neville AM; Cooper EH
Ann Clin Biochem; 1976 Jan; 13(1):283-305. PubMed ID: 56153
[No Abstract] [Full Text] [Related]
56. Telomeres and telomerase in leukaemia and lymphoma.
Davison GM
Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
[TBL] [Abstract][Full Text] [Related]
57. Determinants of delays in treatment initiation in children and adolescents diagnosed with leukemia or lymphoma in Canada.
Dang-Tan T; Trottier H; Mery LS; Morrison HI; Barr RD; Greenberg ML; Franco EL
Int J Cancer; 2010 Apr; 126(8):1936-1943. PubMed ID: 19795458
[TBL] [Abstract][Full Text] [Related]
58. Terminal deoxynucleotidyl transferase.
Hoffbrand AV; Janossy G
Haematologica; 1978 Jun; 63(3):231-40. PubMed ID: 107062
[No Abstract] [Full Text] [Related]
59. Insights on practice variations in the management of lymphoma and leukemia.
Loberiza FR; Cannon AC; Cannon AJ; Bierman PJ
Leuk Lymphoma; 2014 Nov; 55(11):2449-56. PubMed ID: 24410589
[TBL] [Abstract][Full Text] [Related]
60. [Significance of terminal deoxynucleotidyl transferase in patients with acute leukemia and malignant lymphoma: results obtained by immunofluorescence assay (author's transl)].
Ho AD; Hunstein W; Uhl N; Storch HH
Dtsch Med Wochenschr; 1981 May; 106(20):643-7. PubMed ID: 7014159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
